Primary Category:
Treatment Protocols
Disease Category:
Adjuvant Breast, Breast
Status:
Closed
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
E5103 Step 3 registration, registration to the EL112LAB substudy, is closed to accrual on July 29, 2016.
NCT#00433511
